Systematic reviewindependent cross-checkabstract only checked I-ORG-11 standard review

Infections after spleen removal

Risk of infection and death among post-splenectomy patients.

Overview

Bisharat N et al.. J Infect 2001 · PMID 11798256 · DOI 10.1053/jinf.2001.0904

About 3% developed serious infections and 1.4% died of them over about 7 years in older studies.

Does the study support the specific claim? Yes · Methodological quality: low

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

OPSI

How was the study done?

Review

How many people, animals or samples were studied?

19,680

What was actually found?

Infection 3.2%

How large was the observed effect?

3.2%/1.4%

What do the results mean in everyday life?

Infection risk is real; vaccination matters

What are the study's limitations?

Old data

What does it say about Elawady's specific claim?

Supports

Do the results apply to Germany and Europe?

Applicable

What can explicitly not be concluded from this study?

Current risk with vaccines

Scientific in-depth review

1. Full reference

Authors
Bisharat N et al.
Journal
J Infect
Year
2001
Identifier
PMID 11798256 DOI 10.1053/jinf.2001.0904
Verification
verified – PubMed efetch 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

not stated in abstract

2. Research question

Incidence of post-splenectomy sepsis

3. Study design and population

Study design
Systematic review – Literature review with pooled data
Sample size

19,680 patients (6942 analysable)

4. Methods and endpoints

5. Actual results

Results

Infection 3.2%, mortality 1.4% over median 6.9 years; highest in thalassaemia major (8.2% infection, 5.1% mortality) and sickle-cell anaemia.

Absolute risks

not reported

Authors' conclusion

Sepsis incidence low but high mortality, especially in children with haematological disorders.

6. Strengths

  • Large pooled sample

7. Weaknesses

  • Old literature 1966-96
  • Pre-modern vaccination

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
high

9. Assessment of the statistical interpretation

10. Relevance to the specific claim

Supports C-ORG-12 (infection risk) with absolute numbers.

11. Independent contrary findings

12. Transferability to Germany and Europe

Applicable with caution (older data).

13. Overall methodological judgement

Confirms well-known infection risk.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitylow
Risk of biashigh
Precision of resultsmoderate
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

15. Linked fact checks